On August 12, 2020, CEO of NANOLEK Mikhail Nekrasov visited the All-Russian Forum “Health of the nation - the basis of Russia’s prosperity” and took part in the discussion session “Immunoprophylaxis during the pandemic” held under the auspices of the Ministry of Industry and Trade of Russia.
The event was attended by: Nikolay Briko (Director of the Erisman Institute of Public Health, Head of Department of epidemiology and evidence-based medicine at I.M. Sechenov First Moscow State Medical University (MGMU), academician of the Russian Academy of Sciences (RAS), Leila Namazova-Baranova (President of the Union of pediatricians of Russia, academician of RAS), Dmitry Morozov (parliamentarian at the State Duma), Oksana Drapkina (Director of the National medical research center of preventive medicine, chief freelance therapist of the Ministry of Health of Russia), Andrey Prodeus (pediatrician, doctor of medical sciences, immunologist - allergist), Stanislav Gromov (Head of Operations Support Unit at the Department of development of pharmaceutical and medical industry of the Ministry of Trade and Industry of Russia).
The main topics covered at the forum were: vaccination in Russia during the pandemic, scope and schedule of public procurement of vaccines for NCPP (National Calendar of Prophylactic Immunization), efforts taken by the immunobiological industry during the pandemic, the anti-vaccination movement as a global threat, the necessary measures to increase confidence in vaccination.
The absolute majority of speakers showed their proactive position on immunization and responsible approach to their health. Through their example they prove that this is the most effective way to get protected against vaccine-preventable diseases. Misconceptions that exist around vaccination arise from a lack of information, as a consequence of distrust of the population, and due to other factors. One of the talking points expressed by Andrey Produes – “mass immunization is necessary, but it must be a customized solution” – may be taken as the basis of a public movement in support of immunization, which could provide clear answers to any questions related to this topic.
Mikhail Sergeevich Nekrasov, as a representative of the manufacturer of vaccines for the National Calendar of Prophylactic Immunization, commented:
“The strategy pursued by NANOLEK is to produce and localize the production of high-quality modern vaccines as well as combined vaccines. Successful cooperation with leading global providers and Russian research institutes helps us produce world-class vaccines of the highest quality. I would like to emphasize that NANOLEK is the only company that produces inactivated polio vaccines (IPV) (“Polimilex®“) as well as the only manufacturer of a five-component vaccine to prevent diphtheria, tetanus, whooping cough, polio and infections caused by Haemophilus influenzae type b ("Pentaxime®“) in the Russian Federation.
I would also like to mention one of the latest achievements of our production plant, which stayed opened during the pandemic:
a new easy-to-use dosage form of IPV in monodose syringes; a phased transfer of technology to produce the finished dosage form of Pentaxime® vaccine is in its final stage, and stability checks of three industrial batches are now underway. NANOLEK reports on the availability of a vaccine produced at its own plant in the finished dosage form, starting from 2022. It is extremely vital that we initiate the vaccination of all children with 5-component vaccines in order to avoid a decrease in vaccine coverage and deterioration of the epidemiological situation.”